Literature DB >> 35064461

COVID-19 Vaccination and Bariatric Surgery.

Rujittika Mungmungpuntipantip1, Viroj Wiwanitkit2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35064461      PMCID: PMC8782675          DOI: 10.1007/s11695-021-05840-w

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   3.479


× No keyword cloud information.
Dear Editor, We would like to share ideas on “COVID-19 Vaccination and Timing of Bariatric Surgery: Considerations and Concerns for Patients with Severe Obesity [1].” Pazouki et al. noted that “we encourage operating on fully vaccinated patients…… the second shot of the vaccine and the surgery, with more preference for the latter due to its lower likelihood of infection after surgery” [1]. We agree that it is necessary to prevent COVID-19 for the patient. However, we should have a careful consideration for vaccination management. An obese case usually has a high blood viscosity [2], and the COVID-19 vaccine can induce increased blood viscosity [3]. Additionally, after any operation, a change of blood viscosity can occur [4]. Hence, there might be a possible problem of hyperviscosity in an obese subject after vaccination. Based on these factors, the COVID-19 vaccination should be provided before operation. Pre-operation COVID-19 can also help decrease possible COVID-19 infection of the hospitalized patient during pre-operation period. In case that an emergency surgery is required, there must be a good monitoring of complication of post-operation COVID-19 vaccination.
  4 in total

1.  Obesity-related increase in whole blood viscosity includes different profiles according to fat localization.

Authors:  Marie Guiraudou; Emmanuelle Varlet-Marie; Eric Raynaud de Mauverger; Jean-Frédéric Brun
Journal:  Clin Hemorheol Microcirc       Date:  2013       Impact factor: 2.375

Review 2.  Hemorheology in surgery--a review.

Authors:  R Müller; P Musikić
Journal:  Angiology       Date:  1987-08       Impact factor: 3.619

3.  Expected Viscosity After COVID-19 Vaccination, Hyperviscosity and Previous COVID-19.

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

4.  COVID-19 Vaccination and Timing of Bariatric Surgery: Considerations and Concerns for Patients with Severe Obesity.

Authors:  Abdolreza Pazouki; Shahab Shahabi; Erfan Sheikhbahaei; Sommayeh Mokhber; Amir Hossein Davarpanah Jazi; Mohammad Kermansaravi
Journal:  Obes Surg       Date:  2021-09-28       Impact factor: 4.129

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.